Analysed AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) News Sources
Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study
09-05-2026
yahoo.com
Amplia Therapeutics Launches First Stage of Registration-Enabling Trial of Narmafotinib
19-05-2026
yahoo.com
Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders Highlighting the Potential Opportunities for Combination with KRAS Inhibition in Pancreatic Cancer
22-06-2026
yahoo.com
Scientific Paper Detailing Preclinical Studies of Narmafotinib in Pancreatic Cancer Now Online
31-07-2026
yahoo.com
Amplia Therapeutics partners with Lilly on lung cancer combination trial
04-08-2026
proactiveinvestors.com
Amplia Signs Collaboration Agreement With Lilly, Evaluating Narmafotinib Plus Lilly’s Kras G12C Inhibitor, Olomorasib, in Non-small Cell Lung Cancer
04-08-2026
yahoo.com
What is the current price of AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS)?
The current price of AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) is $0.105.
AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) since the previous trading day is $-0.0016.
AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) since the previous trading day is -1.5009%.
What is the most recent average sentiment score for AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS)?
The most recent average sentiment score for AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) is 79 out of 100.
What is the most recent average sentiment for AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS)?
The most recent sentiment for AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) is .
SEC-8K** Filing Available For AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.